Medical/Pharmaceuticals

N.B. Quadriga's Transformative Treatment for Brain Cancers Dosed in First Human Subject

SHANGHAI and NANTONG, China, July 23, 2020 /PRNewswire/ -- N.B. Quadriga (NBQ), a clinical stage biopharmaceutical company developing transformative medicines for brain cancers, today announced that the first patient has been dosed in a Phase 1 study of NBQ72S, also known as QBS10072S, in pati...

2020-07-23 19:00 3870

Zhongchao Inc. Joined Hands with Professional Non-Profit Organizations and 9 Leading Pharma Companies to Carry Out Multi-Year Online Education Project on Diagnosis and Treatment of Primary Liver Cancer

SHANGHAI, July 23, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it joined hands with China Health P...

2020-07-23 18:30 4135

InnoTier launched new sustainable and innovative products in Hong Kong amid COVID-19 pandemic

HONG KONG, July 23, 2020 /PRNewswire/ -- InnoTier, the lifestyle consumer brand under Julius Group, has announced to launch four innovative products inHong Kong with the aim of enabling people to lead more sustainable lives in a rapidly changing world. Against the backdrop of the current global p...

2020-07-23 14:06 7832

Bupa Global Research finds Hong Kong and Mainland China senior executives increasingly concerned about health issues

* A majority of senior executives in Hong Kong (87.6%) and Mainland China (70.5%) have experienced physical and mental health pressure amid the outbreak of COVID-19, but less than 9% seeking professional support * Only 32% and 25.2% of Hong Kong senior executives stated financial stability, and...

2020-07-22 17:38 4185

Ascentage Pharma Announces First Patient Dosed in the Phase Ib Study of MDM2-p53 Inhibitor APG-115 as Single Agent and in Combinations for the Treatment of Hematologic Malignancies in China

SUZHOU, China and ROCKVILLE, Md., July 22, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Phase Ib study of t...

2020-07-22 17:31 2248

Surgere: AutoSphere Gains Altitude - Faster Than Ever

CLEVELAND and TOKYO and ANTWERP, Belgium and AGUASCALIENTES, Mexico, July 21, 2020 /PRNewswire/ -- The Surgere Automotive Supply Chain Community has reached record numbers. The community's amazing growth includes 136 sites in theNorth America and 64 sites in Asia Pacific since January 2020. AutoS...

2020-07-21 22:07 3555

Ortho Care(TM) Again Ranks No. 1 for Service in Diagnostics Industry

RARITAN, N.J., July 21, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a worldwide reputation for top-rated customer service and support, today announced that its Ortho Care™ holistic service and support program was ranked No. 1 in the diagnostics in...

2020-07-21 22:00 2813

LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance

World's first single-use two channel ECG and heart rate biosensor provides 72- hour patient monitoring with remote data access in ambulatory, hospital and home settings FREMONT, Calif., July 21, 2020 /PRNewswire/ -- LifeSignals Group, today announced USFDA 510(k) clearance has been received for ...

2020-07-21 19:00 4297

NICHIBAN to Establish European Subsidiary "NICHIBAN EUROPE GmbH" in Germany

TOKYO, July 21, 2020 /PRNewswire/ -- NICHIBAN CO., LTD., based in Tokyo, announced that it will open a new European subsidiary, "NICHIBANEUROPE GmbH" in Dusseldorf, Germany, in October 2020. As part of the expansion of the company's overseas business, NICHIBAN opened a representative office inDu...

2020-07-21 13:00 1928

D-Link Launches Group Temperature Screening Camera Kit with AI Facial Recognition

TAIPEI, July 21, 2020 /PRNewswire/ -- D-Link today announced the new DCS-9500T Group Temperature Screening Camera Kit that can simultaneously scan up to 30 people with a rapid response time within 30 ms, eliminating queues i...

2020-07-21 10:00 2633

China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor

SHANGHAI and SAN FRANCISCO and WALTHAM, Mass., July 20, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB) and Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that the China National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for ripretinib...

2020-07-20 22:39 4734

JW Therapeutics Acquires Syracuse Biopharma and Its in-Licenses With Eureka Therapeutics' Solid Tumor Technologies in China

SHANGHAI and EMERYVILLE, Calif., July 20, 2020 /PRNewswire/ -- JW Therapeutics , a clinical stage biopharmaceutical company focused on developing, manufacturing and commercializing cell therapies for patients inChina, today announced the acquisition of Syracuse Bio...

2020-07-20 21:33 4597

Connect Biopharma Initiates Phase 2 Clinical Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis

SAN DIEGO and TAICANG, SUZHOU, China, July 20, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and specific immune modulating molecules, today announced that the first patient has been dosed in a Phase 2 clinical tria...

2020-07-20 20:00 2770

New Medical Findings From 10-year Study of 3D Printed Regenerative Implant Osteoplug

SINGAPORE, July 20, 2020 /PRNewswire/ -- Osteopore International Pte Ltd, a global leader in regenerative implants, today revealed new data that demonstrates the long-term safety and efficacy of Osteoplug, a 3D printed bioresorbable polycaprolactone (PCL) bone graft implant, that enables the reg...

2020-07-20 14:41 3716

Docquity partners with global pharma leader to support the continuing education of medical professionals across 7 countries in Asia

SINGAPORE, July 20, 2020 /PRNewswire/ -- Docquity, Southeast Asia's largest professional network of doctors, has partnered with Swiss research-based healthcare company Novartis to deliver bite-sized, continual learning, and education support to doctors across seven countries inAsia. Novartis will...

2020-07-20 11:35 3258

Meta-Analysis from Biosense Webster, Inc. Reveals Positive Effects of Real-Time Ultrasound Imaging During Cardiac Ablation to Treat Arrhythmias

TOKYO, July 20, 2020 /PRNewswire/ -- Biosense Webster, Inc., part of the Johnson & Johnson Medical Devices Companies*, in collaboration with researchers at the Tokyo Medical and Dental University and CTI Clinical Trial Consulting published findings in the  Journal of Cardiovascular Electrophysiol...

2020-07-20 11:25 7656

World Brain Day 2020 "Moves to End Parkinson's Disease"

On July 22, World Brain Day is dedicated to raising awareness to improve the lives of those with Parkinson's Disease and their caregivers LONDON, July 20, 2020 /PRNewswire/ -- On July 22, the World Federation of Neurology (WFN) is partnering with the International Parkinson and Movement Disorder...

2020-07-20 09:00 2547

PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit

HONG KONG, July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformité Européene (CE) Mark approval for its PHASIFY™ VIRAL RNA Extraction Kit. The CE marking confirms that PHASIFY™ VIRAL complies with the European In-Vitro D...

2020-07-20 09:00 4183

Bridging Study in China Completed for NASH Drug Candidate ASC40

HANGZHOU and SHAOXING, China, July 20, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that a single-dose, pharmacokinetic bridging study of non-alcoholic steatohepatitis (NASH) drug candidate ASC40 (TVB-2640) in 34 Chinese subjects has been completed and data indicate...

2020-07-20 08:30 4855

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, July 20, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed...

2020-07-20 08:00 9294
1 ... 352353354355356357358 ... 396

Week's Top Stories